Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 3
1986 1
1987 1
1988 2
1989 5
1990 9
1991 4
1992 8
1993 5
1994 16
1995 19
1996 17
1997 35
1998 27
1999 42
2000 43
2001 46
2002 44
2003 67
2004 80
2005 82
2006 80
2007 92
2008 106
2009 85
2010 94
2011 104
2012 105
2013 138
2014 132
2015 145
2016 138
2017 152
2018 139
2019 161
2020 328
2021 3027
2022 5258
2023 3487
2024 885

Text availability

Article attribute

Article type

Publication date

Search Results

13,698 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020-2023.
Yan Y, Ito K, Fukuda H, Nojiri S, Urasaki W, Yamamoto T, Horiuchi Y, Hori S, Takahashi K, Naito T, Tabe Y. Yan Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2337984. doi: 10.1080/21645515.2024.2337984. Epub 2024 Apr 15. Hum Vaccin Immunother. 2024. PMID: 38622888 Free PMC article.
Although having four doses or less was found to be associated with higher risk of infection, the optimal constitution and intervals for effective booster vaccines warrant further investigations....
Although having four doses or less was found to be associated with higher risk of infection, the optimal constitution and intervals for effe …
Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines.
Russell CA, Fouchier RAM, Ghaswalla P, Park Y, Vicic N, Ananworanich J, Nachbagauer R, Rudin D. Russell CA, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2336357. doi: 10.1080/21645515.2024.2336357. Epub 2024 Apr 15. Hum Vaccin Immunother. 2024. PMID: 38619079 Free PMC article. Review.
These findings highlight the need for alternative vaccine development platforms. Recently, vaccines based on mRNA technology have demonstrated efficacy against SARS-CoV-2 and respiratory syncytial virus and are under clinical evaluation for seasonal influenza. We di …
These findings highlight the need for alternative vaccine development platforms. Recently, vaccines based on mRNA technology h …
Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan.
Jaber HM, Ebdah S, Al Haj Mahmoud SA, Abu-Qatouseh L, Jaber YH. Jaber HM, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2333104. doi: 10.1080/21645515.2024.2333104. Epub 2024 Apr 7. Hum Vaccin Immunother. 2024. PMID: 38584118 Free PMC article.
Various COVID-19 vaccines can affect the immune system. Discrepancies have been noted in immune system characteristics, such as T-lymphocyte levels, between vaccinated and non-vaccinated individuals. ...All COVID-19 vaccines administered in Jordan were effective, wi …
Various COVID-19 vaccines can affect the immune system. Discrepancies have been noted in immune system characteristics, such as T-lym …
Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary.
Pather S, Muik A, Rizzi R, Mensa F. Pather S, et al. Expert Rev Vaccines. 2024 Dec 31;23(1):463-466. doi: 10.1080/14760584.2024.2320858. Epub 2024 Apr 5. Expert Rev Vaccines. 2024. PMID: 38578120 Free article.
Therefore, BioNTech and Pfizer developed updated versions of the BNT162b2 vaccine that contain mRNA from certain variants. These new vaccines are called variant-adapted COVID-19 mRNA vaccines.Another company, Moderna, has also developed their own varia …
Therefore, BioNTech and Pfizer developed updated versions of the BNT162b2 vaccine that contain mRNA from certain variants. These new …
Exploration of the integration of microbiology and immunology emerging topics into undergraduate medical education.
Bauer ME, Akbar S, Bauler TJ, Chacon J, McClelland EE, Staudaher S, Zhao Y. Bauer ME, et al. Med Educ Online. 2024 Dec 31;29(1):2336331. doi: 10.1080/10872981.2024.2336331. Epub 2024 Apr 5. Med Educ Online. 2024. PMID: 38577972 Free PMC article.
RESULTS: The top emerging topics that were added to the curriculum or considered for addition in the last 10 years included COVID-19, Zika virus, mRNA vaccines, and Mpox (formerly known as monkeypox). Most respondents reported lectures and active learning as the maj …
RESULTS: The top emerging topics that were added to the curriculum or considered for addition in the last 10 years included COVID-19, Zika v …
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Ackerson BK, Bruxvoort KJ, Qian L, Sy LS, Qiu S, Tubert JE, Lee GS, Ku JH, Florea A, Luo Y, Bathala R, Stern J, Choi SK, Takhar HS, Aragones M, Marks MA, Anderson EJ, Zhou CK, Sun T, Talarico CA, Tseng HF. Ackerson BK, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2335052. doi: 10.1080/21645515.2024.2335052. Epub 2024 Apr 4. Hum Vaccin Immunother. 2024. PMID: 38575149 Free PMC article.
Assessment of long-term effectiveness of bivalent COVID-19 vaccines against circulating sublineages is important to inform the potential need for vaccination with updated vaccines. ...Periodic revaccination with vaccines targeting emerging variants may be imp …
Assessment of long-term effectiveness of bivalent COVID-19 vaccines against circulating sublineages is important to inform the potent …
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.
Jarrot PA, Mirouse A, Ottaviani S, Cadiou S, Salmon JH, Liozon E, Parreau S, Michaud M, Terrier B, Gavand PE, Trefond L, Lavoiepierre V, Keraen J, Rekassa D, Bouldoires B, Weitten T, Roche D, Poulet A, Charpin C, Grobost V, Hermet M, Pallure M, Wackenheim C, Karkowski L, Grumet P, Rogier T, Belkefi N, Pestre V, Broquet E, Leurs A, Gautier S, Gras V, Gilet P, Holubar J, Sivova N, Schleinitz N, Durand JM, Castel B, Petrier A, Arcani R, Gramont B, Guilpain P, Lepidi H, Weiller PJ, Micallef J, Saadoun D, Kaplanski G. Jarrot PA, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2334084. doi: 10.1080/21645515.2024.2334084. Epub 2024 Apr 2. Hum Vaccin Immunother. 2024. PMID: 38563792 Free PMC article.
First, based on the French pharmacovigilance database, we estimated the RR of PMR and GCA cases in individuals aged over 50 who developed their initial symptoms within one month of receiving the BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines …
First, based on the French pharmacovigilance database, we estimated the RR of PMR and GCA cases in individuals aged over 50 who developed th …
Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan.
Cai G, Liu S, Lu Y, Takaki Y, Matsumoto F, Yoshikawa A, Taguri T, Xie J, Arima K, Mizukami S, Wu J, Yamamoto T, Hasegawa M, Tien Huy N, Saito M, Takeuchi S, Morita K, Aoyagi K, He F. Cai G, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2322795. doi: 10.1080/21645515.2024.2322795. Epub 2024 Mar 22. Hum Vaccin Immunother. 2024. PMID: 38517220 Free PMC article.
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial.
Naficy A, Kuxhausen A, Seifert H, Hastie A, Leav B, Miller J, Anteyi K, Mwakingwe-Omari A. Naficy A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2327736. doi: 10.1080/21645515.2024.2327736. Epub 2024 Mar 21. Hum Vaccin Immunother. 2024. PMID: 38513689 Free PMC article. Clinical Trial.
The results of our study showed that an mRNA-based COVID-19 booster vaccine could be given at the same time as the seasonal influenza vaccine.When given together, both vaccines led to immune responses and had side effects that were similar to those observed when the …
The results of our study showed that an mRNA-based COVID-19 booster vaccine could be given at the same time as the seasonal influenza …
Formulation development of a stable influenza recombinant neuraminidase vaccine candidate.
Li B, Ustyugova IV, Szymkowicz L, Zhu S, Ming M, Fung KYY, Cortés G, James DA, Hrynyk M, Rahman N, Brookes RH, Ausar SF. Li B, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2304393. doi: 10.1080/21645515.2024.2304393. Epub 2024 Mar 18. Hum Vaccin Immunother. 2024. PMID: 38497413 Free PMC article.
Current influenza vaccines could be augmented by including recombinant neuraminidase (rNA) protein antigen to broaden protective immunity and improve efficacy. ...
Current influenza vaccines could be augmented by including recombinant neuraminidase (rNA) protein antigen to broaden protective immu …
13,698 results
You have reached the last available page of results. Please see the User Guide for more information.